Drug Research - Latest News & Updates on Drug Research

Regulatory Intelligence Supporting Accelerated Drug Development

Yuvraj — Mon, 10 Aug 2026 10:34:07 +0000

The global pharmaceutical environment is becoming increasingly complex, with regulatory agencies frequently updating guidelines to keep pace with scientific advancements and emerging health threats. In this context, the role of regulatory intelligence supporting accelerated drug development has never been more critical. Pharmaceutical organizations must proactively monitor and interpret changes in the regulatory environment to ensure […]

The post Regulatory Intelligence Supporting Accelerated Drug Development first appeared on World Pharma Today.

Predictive Formulation Design in Oral Solid Dose Development

Yuvraj — Fri, 07 Aug 2026 11:56:30 +0000

The integration of computational modeling and algorithmic analysis is currently redefining the methodology behind tablet and capsule creation in the pharmaceutical sector. Pharmaceutical organizations are increasingly transitioning away from empirical trial and error approaches in favor of data driven methodologies that prioritize speed and scientific precision. This shift is particularly evident in the adoption of […]

The post Predictive Formulation Design in Oral Solid Dose Development first appeared on World Pharma Today.

Bristol Myers Squibb Expands Strategic AI Partnership with Schrödinger

Yuvraj — Thu, 06 Aug 2026 11:56:27 +0000

Bristol Myers Squibb has expanded its ongoing strategic partnership with Schrödinger through a new agreement to deploy the agentic AI co-scientist platform, Bunsen, across its research operations. Building upon an established collaboration in which Bristol Myers Squibb already utilizes Schrödinger computational tools, this enterprise-wide integration is designed to help scientific teams evaluate drug discovery AI […]

The post Bristol Myers Squibb Expands Strategic AI Partnership with Schrödinger first appeared on World Pharma Today.

Immediate Release Technologies Advancing Oral Drug Performance

Yuvraj — Thu, 06 Aug 2026 09:55:46 +0000

The pharmaceutical industry is experiencing a significant shift in the development of fast acting oral medications, driven by the need for rapid onset of action and improved patient adherence. The optimization of drug release profiles is fundamental to therapeutic success, particularly for conditions requiring quick symptomatic relief. To meet these demands, developers are increasingly adopting […]

The post Immediate Release Technologies Advancing Oral Drug Performance first appeared on World Pharma Today.

GLP-1 Therapies Broadening Clinical Treatment Pathways

Yuvraj — Wed, 05 Aug 2026 09:42:47 +0000

The pharmaceutical industry is currently witnessing a significant expansion in the clinical utility of glucagon-like peptide 1 receptor agonists, moving well beyond their initial applications in type 2 diabetes and obesity management. As more data from large-scale cardiovascular and renal outcome trials becomes available, the medical community is recognizing that these therapies have systemic benefits […]

The post GLP-1 Therapies Broadening Clinical Treatment Pathways first appeared on World Pharma Today.

Combination Therapeutics Strengthening GLP-1 Treatment

Yuvraj — Wed, 05 Aug 2026 09:34:20 +0000

The pharmaceutical sector is currently undergoing a significant transition from monotherapy to multi-receptor targeting in the management of metabolic disorders. While single-agent glucagon-like peptide 1 receptor agonists have provided a fundamental foundation for treating type 2 diabetes and obesity, the limitations of targeting a single biological pathway are becoming increasingly apparent. Consequently, the industry is […]

The post Combination Therapeutics Strengthening GLP-1 Treatment first appeared on World Pharma Today.

Emerging GLP-1 Therapies Redefining Metabolic Treatment

Yuvraj — Wed, 05 Aug 2026 08:59:05 +0000

The pharmaceutical sector is currently undergoing a fundamental shift as new classes of metabolic agents move through the clinical pipeline. While injectable glucagon-like peptide 1 receptor agonists have set a high bar for efficacy in weight loss and glycemic control, the industry is now focused on expanding the reach of these treatments. The development of […]

The post Emerging GLP-1 Therapies Redefining Metabolic Treatment first appeared on World Pharma Today.

AI Accelerating Next-Generation GLP-1 Drug Discovery

Yuvraj — Wed, 05 Aug 2026 08:16:36 +0000

The pharmaceutical industry is currently witnessing a significant shift in how metabolic therapies are conceptualized and developed, specifically through the integration of computational intelligence. The traditional methodology for identifying and validating glucagon-like peptide 1 receptor agonists has historically been a labor-intensive process, often spanning over a decade from initial lead identification to market approval. However, […]

The post AI Accelerating Next-Generation GLP-1 Drug Discovery first appeared on World Pharma Today.

Polymer Science Advancing Sustained Drug Delivery

Yuvraj — Tue, 21 Jul 2026 12:58:57 +0000

The development of sustained-release drug delivery systems has transformed the treatment of chronic diseases by allowing for the controlled release of therapeutic agents over extended periods. This approach reduces the frequency of administration, improves patient compliance, and maintains drug concentrations within the therapeutic window, minimizing the peaks and troughs associated with conventional dosage forms. Polymer […]

The post Polymer Science Advancing Sustained Drug Delivery first appeared on World Pharma Today.

Vascular Drug Targeting Enhancing Precision Delivery

Yuvraj — Tue, 21 Jul 2026 12:52:09 +0000

The ability to deliver therapeutic agents specifically to diseased tissues while sparing healthy cells remains a central objective in pharmaceutical research. Traditional systemic drug delivery often results in suboptimal concentrations at the target site and significant off-target toxicity, which can limit the dose and duration of treatment. Vascular drug targeting enhancing precision delivery offers a […]

The post Vascular Drug Targeting Enhancing Precision Delivery first appeared on World Pharma Today.